HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Wen Chen Selected Research

Ultrasonic Therapy

1/2019Ultrasound therapy reduces persistent post-thoracotomy tactile allodynia and spinal substance P expression in rats.
2/2018Local Application of Ultrasound Attenuates Neuropathic Allodynia and Proinflammatory Cytokines in Rats After Thoracotomy.
1/2017Exercise Combined With Ultrasound Attenuates Neuropathic Pain in Rats Associated With Downregulation of IL-6 and TNF-α, but With Upregulation of IL-10.
10/2016Therapeutic Ultrasound and Treadmill Training Suppress Peripheral Nerve Injury-Induced Pain in Rats.
1/2015Therapeutic ultrasound suppresses neuropathic pain and upregulation of substance P and neurokinin-1 receptor in rats after peripheral nerve injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Wen Chen Research Topics

Disease

22Pain (Aches)
06/2022 - 09/2003
11Neoplasms (Cancer)
10/2021 - 06/2005
9Hyperalgesia
06/2022 - 09/2013
8Hypersensitivity (Allergy)
06/2022 - 07/2013
5Inflammation (Inflammations)
01/2022 - 07/2012
5Neuroblastoma
01/2020 - 06/2010
5Neuralgia (Stump Neuralgia)
01/2020 - 06/2012
4Rheumatoid Arthritis
01/2017 - 07/2012
4Peripheral Nerve Injuries
01/2017 - 09/2013
4Apnea
10/2012 - 01/2010
3Fibrosis (Cirrhosis)
09/2019 - 04/2016
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018 - 01/2013
3Wounds and Injuries (Trauma)
01/2017 - 01/2004
3Body Weight (Weight, Body)
07/2015 - 02/2013
3Postoperative Pain
08/2014 - 07/2013
3Lung Neoplasms (Lung Cancer)
11/2013 - 12/2007
3Neoplasm Metastasis (Metastasis)
11/2013 - 12/2007
2Infections
01/2022 - 05/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2018 - 08/2015
2Burns
01/2017 - 01/2004
2Adenocarcinoma
03/2016 - 07/2013
2Breast Neoplasms (Breast Cancer)
12/2014 - 07/2005
2Infarction (Infarctions)
01/2014 - 03/2004
2Nasopharyngeal Carcinoma
11/2012 - 09/2007
1Peripheral Nervous System Diseases (PNS Diseases)
02/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022
1Exanthema (Rash)
03/2021
1Phlebitis
03/2021
1Hematologic Diseases (Blood Diseases)
03/2021
1Suppuration
12/2020
1Chronic Hepatitis C
08/2020
1Cytopenia
03/2020
1Lymphoma (Lymphomas)
03/2020
1B-Cell Leukemia (Leukemia, B Cell)
03/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2020
1Neuroinflammatory Diseases
01/2020
1Essential Hypertension
01/2020
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2020
1Pneumococcal Infections
01/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Osteosarcoma (Osteogenic Sarcoma)
01/2020
1Cardiotoxicity
09/2019

Drug/Important Bio-Agent (IBA)

15CytokinesIBA
06/2022 - 06/2012
6Interleukin-6 (Interleukin 6)IBA
12/2020 - 07/2013
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 01/2013
5Substance PIBA
01/2019 - 07/2014
5Analgesics (Analgesic Drugs)IBA
08/2016 - 09/2003
5Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric
10/2015 - 01/2010
3diphenidol (Vontrol)FDA Link
03/2015 - 01/2012
2AntibodiesIBA
10/2021 - 11/2013
2Pharmaceutical PreparationsIBA
10/2021 - 01/2012
2Interleukin-10 (Interleukin 10)IBA
12/2020 - 01/2017
2erinacine AIBA
01/2020 - 01/2020
2Phospholipases A2 (Phospholipase A2)IBA
04/2018 - 07/2012
2Streptozocin (Streptozotocin)FDA Link
01/2018 - 01/2013
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2017 - 07/2012
2Insulin (Novolin)FDA Link
01/2017 - 07/2015
2Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
08/2016 - 03/2013
2Heme Oxygenase-1IBA
08/2015 - 07/2012
2caramiphenIBA
01/2015 - 01/2012
2Voltage-Gated Sodium ChannelsIBA
01/2015 - 08/2013
2quinolineIBA
01/2015 - 07/2011
2Glucose (Dextrose)FDA LinkGeneric
12/2014 - 12/2007
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2014 - 07/2013
2ThrombinFDA Link
10/2013 - 05/2013
2carbetapentane (pentoxyverine)IBA
08/2013 - 01/2012
2HSP72 Heat-Shock ProteinsIBA
10/2008 - 09/2007
1AcetoneIBA
06/2022
1Bendamustine HydrochlorideFDA Link
02/2022
1polatuzumab vedotinIBA
02/2022
1Rituximab (Mabthera)FDA Link
02/2022
1Interleukin-18 (Interleukin 18)IBA
01/2022
1Boronic AcidsIBA
10/2021
1gadobutrolIBA
10/2021
1N-Acetylneuraminic Acid (Sialic Acid)IBA
10/2021
1GadoliniumIBA
10/2021
1AmidesIBA
10/2021
1Contrast MediaIBA
10/2021
1Antiviral Agents (Antivirals)IBA
08/2020
1AzolesIBA
03/2020
1venetoclaxIBA
03/2020
1Complex MixturesIBA
01/2020
1Glial Fibrillary Acidic ProteinIBA
01/2020
1Particulate MatterIBA
01/2020
1Purinergic Receptors (Receptors, Purine)IBA
01/2020
1erinacine SIBA
01/2020
1fibroblast growth factor 21IBA
01/2020
1Capsules (Microcapsules)IBA
01/2020
1CalciumIBA
01/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
09/2019

Therapy/Procedure

5Ultrasonic Therapy
01/2019 - 01/2015
5Therapeutics
07/2015 - 11/2012
4Thoracotomy
06/2022 - 02/2018
3Transcutaneous Electric Nerve Stimulation (TENS)
03/2015 - 07/2014
3Intravenous Infusions
10/2012 - 01/2011
2Ligation
01/2020 - 09/2013
2Aftercare (After-Treatment)
01/2018 - 07/2012
1Withholding Treatment
02/2022
1Catheters
03/2021